OncoC4 Expands Scientific Advisory Board with Appointment of Heather A. Wakelee, MD, FASCO
“We are honored to welcome Heather to the OncoC4 SAB, an international expert with decades of leadership experience in the treatment of lung cancer,” said Yang Liu, PhD, Co-Founder, CEO and CSO of OncoC4.
- “We are honored to welcome Heather to the OncoC4 SAB, an international expert with decades of leadership experience in the treatment of lung cancer,” said Yang Liu, PhD, Co-Founder, CEO and CSO of OncoC4.
- By leveraging universal pathways, OncoC4 has the potential to change the treatment paradigm for many common and aggressive cancers with high unmet needs.
- Currently she serves as Deputy Director of the Stanford Cancer Institute and is the Division Chief of Medical Oncology.
- She is the Principal Investigator on numerous clinical trials and has held advisory board roles with multiple international pharmaceutical companies.